Skip to main content
SpringerLink
Log in

Creatine supplementation in health and disease: What is the evidence for long-term efficacy?

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Creatine supplementation is an established ergogenic aid in sports and is now claimed to have therapeutical applications in a variety of diseases. The available literature mainly covers the short-term (one to several weeks) effects of creatine supplementation on skeletal muscle function in health and disease, which is of little help to evaluate the long-term (two or more months) potential of creatine as a drug in chronic disorders, such as neurodegenerative diseases or muscular dystrophies. Recent findings in healthy humans indicate that the beneficial effect on muscle function and muscle total creatine content may disappear when creatine is continuously ingested for more than two or three months. The mechanism for this habituation to chronic creatine exposure is poorly understood. The primary purpose of the present review article is to critically evaluate the available evidence for long-term efficacy of creatine administration and to hypothesize about ways to optimize creatine administration regimens.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hespel P, Op`t Eijnde B, Derave W, Richter EA: Creatine supplementation: Exploring the role of the creatine kinase/phosphocreatine system in human muscle. Can J Appl Physiol 26(suppl): 79-103, 2001

    Google Scholar 

  2. Matthews RT, Ferrante RJ, Klivenyi P, Yang L, Klein AM, Mueller G, Kaddurah-Daouk R, Beal MF: Creatine and cyclocreatine attenuate MPTP neurotoxicity. Exp Neurol 157: 142-149, 1999

    Google Scholar 

  3. Matthews RT, Yang L, Jenkins BG, Ferrante RJ, Rosen BR, Kaddurah-Daouk R, Beal MF: Neuroprotective effect of creatine and cyclocreatine in animal models of Huntington's disease. J Neurosci 18: 156-163, 1998

    Google Scholar 

  4. Klivenyi P, Ferrante J, Matthews RT, Bogdanov MB, Klein AM, Andreassen OA, Mueller G, Wermer M, Kaddurah-Daouk R, Beal MF: Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med 5: 347-350, 1999

    Google Scholar 

  5. Heinanen K, Nanto-Salonen K, Komu M, Erkintalo M, Alanen A, Heinonen OJ, Pulkki K, Nikoskelainen E, Sipila I, Simell O: Creatine corrects muscle 31P spectrum in gyrate atrophy with hyperornithinaemia. Eur J Clin Invest 29: 1060-1065, 1999

    Google Scholar 

  6. Vorgerd M, Grehl T, Jager M, Muller K, Freitag G, Patzold T, Bruns N, Fabian K, Tegenthoff M, Mortier W, Luttmann A, Zange J, Malin JP: Creatine therapy in myophosphorylase deficiency (McArdle discase): A placebo-controlled crossover trial. Arch Neurol 57: 956-963, 2000

    Google Scholar 

  7. Felber S, Skladal D, Wyss M, Kremser C, Koller A, Sperl W: Oral creatine supplementation in Duchenne muscular dystrophy: A clinical and 31P magnetic resonance spectroscopy study. Neurol Res 22: 145-150, 2000

    Google Scholar 

  8. Item CB, Stockler-Ipsiroglu S, Stromberger C, Muhl A, Alessandri MG, Bianchi MC, Tosetti M, Fornai F, Cioni G: Arginine:glycine amidinotransferase deficiency: The third inborn error of creatine metabolism in humans. Am J Hum Genet 69: 1127-1133, 2001

    Google Scholar 

  9. Stockler S, Hanefeld F, Frahm J: Creatine replacement therapy in guanidinoacetate methyltransferase deficiency, a novel inborn error of metabolism. Lancet 348: 789-790, 1996

    Google Scholar 

  10. Gordon A, Hultman E, Kaijser L, Kristjansson S, Rolf CJ, Nyquist O, Sylven C: Creatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance. Cardiovasc Res 30: 413-418, 1995

    Google Scholar 

  11. Tarnopolsky MA: Potential benefits of creatine monohydrate supplementation in the elderly. Curr Opin Clin Nutr Metab Care 3: 497-502, 2000

    Google Scholar 

  12. Ness SR, McCarty MF: Does supplemental creatine prevent herpes recurrences? Med Hypotheses 57: 310-312, 2001

    Google Scholar 

  13. Harris RC, Söderlund K, Hultman E: Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clin Sci 83: 367-374, 1992

    Google Scholar 

  14. Greenhaff PL, Bodin K, Soderlund K, Hultman E: Effect of oral creatine supplementation on skeletal muscle phosphocreatine resynthesis. Am J Physiol 266: E725-E730, 1994

    Google Scholar 

  15. Harris RC, Hultman E, Nordesjo LO: Glycogen, glycolytic intermediates and high-energy phosphates determined in biopsy samples of musculus quadriceps femoris of man at rest. Methods and variance of values. Scand J Clin Lab Invest 33: 109-120, 1974

    Google Scholar 

  16. Casey A, Constantin-Teodosiu D, Howell S, Hultman E, Greenhaff PL: Creatine ingestion favorably affects performance and muscle metabolism during maximal exercise in humans. Am J Physiol (Endo Metab) 271: E31-E37, 1996

    Google Scholar 

  17. Snow RJ, McKenna MJ, Selig SE, Kemp J, Stathis CG, Zhao S: Effect of creatine supplementation on sprint exercise performance and muscle metabolism. J Appl Physiol 84: 1667-1673, 1998

    Google Scholar 

  18. Vandenberghe K, Van Hecke P, Van Leemputte M, Vanstapel F, Hespel P: Phosphocreatine resynthesis is not affected by creatine loading. Med Sci Sports Exerc 31: 236-242, 1999

    Google Scholar 

  19. Eijnde BO, Urso B, Richter EA, Greenhaff PL, Hespel P: Effect of oral creatine supplementation on human muscle GLUT4 protein content after immobilization. Diabetes 50: 18-23, 2001

    Google Scholar 

  20. Nelson AG, Arnall DA, Kokkonen J, DAY AR, Evans J: Muscle glycogen supercompensation is enhanced by prior creatine supplementation. Med Sci Sports Exerc 33: 1096-1100, 2001

    Google Scholar 

  21. Robinson TM, Sewell DA, Hultman E, Greenhaff PL: Role of submaximal exercise in promoting creatine and glycogen accumulation in human skeletal muscle. J Appl Physiol 87: 598-604, 1999

    Google Scholar 

  22. Eijnde BO, Richter EA, Henquin JC, Kiens B, Hespel P: Effect of creatine supplementation on creatine and glycogen content in rat skeletal muscle. Acta Physiol Scand 171: 169-176, 2001

    Google Scholar 

  23. Horn M, Frantz S, Remkes H, Laser A, Urban B, Mettenleiter A, Schnackerz K, Neubauer S: Effects of chronic dietary creatine feeding on cardiac energy metabolism and on creatine content in heart, skeletal muscle, brain, liver and kidney. J Mol Cell Cardiol 30: 277-284, 1998

    Google Scholar 

  24. Tarnopolsky M, Martin J: Creatine monohydrate increases strength in patients with neuromuscular disease. Neurology 52: 854-857, 1999

    Google Scholar 

  25. Walter MC, Lochmuller H, Reilich P, Klopstock T, Huber R, Hartard M, Hennig M, Pongratz D, Muller-Felber W: Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study. Neurology 54: 1848-1850, 2000

    Google Scholar 

  26. Klopstock T, Querner V, Schmidt F, Gekeler F, Walter M, Hartard M, Henning M, Gasser T, Pongratz D, Straube A, Dieterich M, Muller-Felber W: A placebo-controlled crossover trial of creatine in mitochondrial diseases. Neurology 55: 1748-1751, 2000

    Google Scholar 

  27. Vandenberghe K, Goris M, Van Hecke P, Van Leemputte M, Vangerven L, Hespel P: Long-term creatine intake is beneficial to muscle performance during resistance training. J Appl Physiol 83: 2055-2063, 1997

    Google Scholar 

  28. Hespel P, Op`t Eijnde B, Van Leemputte M, Urso B, Greenhaff PL, Labarque V, Dymarkowski S, Van Hecke P, Richter EA: Oral creatine supplementation facilitates the rehabilitation of disuse atrophy and alters expression of muscle myogenic factors in humans. J Physiol (Lond) 536: 625-633, 2001

    Google Scholar 

  29. Volek JS, Duncan ND, Mazzetti SA, Staron RS, Putukian M, Gómez AL, Pearson DR, Fink WJ, Kraemer WJ: Performance and muscle fiber adaptations to creatine supplementation and heavy resistance training. Med Sci Sports Exerc 31: 1147-1156, 1999

    Google Scholar 

  30. Steenge GR: Factors affecting creatine accumulation in human skeletal muscle. PhD-thesis, University of Nottingham, 1999

  31. Guerrero-Ontiveros ML, Wallimann T: Creatine supplementation in health and disease. Effects of chronic creatine ingestion in vivo: Down-regulation of the expression of creatine transporter isoforms in skeletal muscle. Mol Cell Biochem 184: 427-437, 1998

    Google Scholar 

  32. Loike JD, Zalutsky DL, Kaback E, Miranda AF, Silverstein SC: Extracellular creatine regulates creatine transport in rat and human muscle cells. Proc Natl Acad Sci USA 85: 807-811, 1988

    Google Scholar 

  33. Murphy R, McConell G, Cameron-Smith D, Watt K, Ackland L, Walzel B, Wallimann T, Snow R: Creatine transporter protein content, localization, and gene expression in rat skeletal muscle. Am J Physiol (Cell Physiol) 280: C415-C422, 2001

    Google Scholar 

  34. Bianchi MC, Tosetti M, Fornai F, Alessandri' MG, Cipriani P, De Vito G, Canapicchi R: Reversible brain creatine deficiency in two sisters with normal blood creatine level. Ann Neurol 47: 511-513, 2000

    Google Scholar 

  35. Salomons GS, van Dooren SJ, Verhoeven NM, Cecil KM, Ball WS, Degrauw TJ, Jakobs C: X-linked creatine-transporter gene (SLC6A8) defect: A new creatine-deficiency syndrome. Am J Hum Genet 68: 1497-1500, 2001

    Google Scholar 

  36. Cecil KM, Salomons GS, Ball WS Jr, Wong B, Chuck G, Verhoeven NM, Jakobs C, Degrauw TJ: Irreversible brain creatine deficiency with elevated serum and urine creatine: A creatine transporter defect? Ann Neurol 49: 401-404, 2001

    Google Scholar 

  37. Heinanen K, Nanto-Salonen K, Komu M, Erkintalo M, Heinonen OJ, Pulkki K, Valtonen M, Nikoskelainen E, Alanen A, Simell O: Muscle creatine phosphate in gyrate atrophy of the choroid and retina with hyperornithinaemia — clues to pathogenesis. Eur J Clin Invest 29: 426-431, 1999

    Google Scholar 

  38. Sipilä I, Rapola J, Simell O, Vannas A: Supplementary creatine as a treatment for gyrate atrophy of the choroid and retina. N Engl J Med 304: 867-870, 1981

    Google Scholar 

  39. Mazzini L, Balzarini C, Colombo R, Mora G, Pastore I, De Ambrogio R, Caligari M: Effects of creatine supplementation on exercise performance and muscular strength in amyotrophic lateral sclerosis: Preliminary results. J Neurol Sci 191: 139-144, 2001

    Google Scholar 

  40. Green AL, Simpson EJ, Littlewood JJ, MacDonald IA, Greenhaff PL: Carbohydrate ingestion augments creatine retention during creatine feeding in humans. Acta Physiol Scand 158: 195-202, 1996

    Google Scholar 

  41. Steenge GR, Simpson EJ, Greenhaff PL: Protein-and carbohydrate-induced augmentation of whole body creatine retention in humans. J Appl Physiol 89: 1165-1171, 2000

    Google Scholar 

  42. Steenge GR, Lambourne J, Casey A, MacDonald IA, Greenhaff PL: Stimulatory effect of insulin on creatine accumulation in human skeletal muscle. Am J Physiol 275: E974-E979, 1998

    Google Scholar 

  43. Green AL, Hultman E, MacDonald IA, Sewell DA, Greenhaff PL: Carbohydrate ingestion augments skeletal muscle creatine accumulation during creatine supplementation in humans. Am J Physiol (Endocrinol Metab) 271: E821-E826, 1996

    Google Scholar 

  44. Hultman E, Soderlund K, Timmons JA, Cederblad G, Greenhaff PL: Muscle creatine loading in men. J Appl Physiol 81: 232-237, 1996

    Google Scholar 

  45. Febbraio MA, Flanagan TR, Snow RJ, Zhao S, Carey MF: Effect of creatine supplementation on intramuscular TCr, metabolism and performance during intermittent, supramaximal exercise in humans. Acta Physiol Scand 155: 387-395, 1995

    Google Scholar 

  46. Parise G, Mihic S, MacLennan D, Yarasheski KE, Tarnopolsky MA: Effects of acute creatine monohydrate supplementation on leucine kinetics and mixed-muscle protein synthesis. J Appl Physiol 91: 1041-1047, 2001

    Google Scholar 

  47. McKenna MJ, Morton J, Selig SE, Snow RJ: Creatine supplementation increases muscle total creatine but not maximal intermittent exercise performance. J Appl Physiol 87: 2244-2252, 1999

    Google Scholar 

  48. Balsom PD, Soderlund K, Sjodin B, Ekblom B: Skeletal muscle metabolism during short duration high-intensity exercise: Influence of creatine supplementation. Acta Physiol Scand 154: 303-310, 1995

    Google Scholar 

  49. Bellinger BM, Bold A, Wilson GR, Noakes TD, Myburgh KH: Oral creatine supplementation decreases plasma markers of adenine nucleotide degradation during a 1-h cycle test. Acta Physiol Scand 170: 217-224, 2000

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Exercise Physiology and Biomechanics Laboratory, Department of Kinesiology, Faculty of Physical Education and Physiotherapy, Catholic University of Leuven, Leuven, Belgium

    Wim Derave, Bert O. Eijnde & Peter Hespel

Authors
  1. Wim Derave
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bert O. Eijnde
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter Hespel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Derave, W., Eijnde, B.O. & Hespel, P. Creatine supplementation in health and disease: What is the evidence for long-term efficacy?. Mol Cell Biochem 244, 49–55 (2003). https://doi.org/10.1023/A:1022439302975

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1022439302975

Search

Navigation